Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

Cited In for PubMed (Select 12930822)

1.

PINK1 Is Dispensable for Mitochondrial Recruitment of Parkin and Activation of Mitophagy in Cardiac Myocytes.

Kubli DA, Cortez MQ, Moyzis AG, Najor RH, Lee Y, Gustafsson ÅB.

PLoS One. 2015 Jun 25;10(6):e0130707. doi: 10.1371/journal.pone.0130707. eCollection 2015.

2.

Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.

Van Rompuy AS, Oliveras-Salvá M, Van der Perren A, Corti O, Van den Haute C, Baekelandt V.

Mol Neurodegener. 2015 Jun 23;10(1):23. doi: 10.1186/s13024-015-0017-8.

3.

Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines.

Shaltouki A, Sivapatham R, Pei Y, Gerencser AA, Momčilović O, Rao MS, Zeng X.

Stem Cell Reports. 2015 May 12;4(5):847-59. doi: 10.1016/j.stemcr.2015.02.019. Epub 2015 Apr 2.

4.

Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans.

Chakraborty S, Chen P, Bornhorst J, Schwerdtle T, Schumacher F, Kleuser B, Bowman AB, Aschner M.

Metallomics. 2015 May 13;7(5):847-56. doi: 10.1039/c5mt00052a. Epub 2015 Mar 13.

PMID:
25769119
5.

Combined QTL and selective sweep mappings with coding SNP annotation and cis-eQTL analysis revealed PARK2 and JAG2 as new candidate genes for adiposity regulation.

Roux PF, Boitard S, Blum Y, Parks B, Montagner A, Mouisel E, Djari A, Esquerré D, Désert C, Boutin M, Leroux S, Lecerf F, Le Bihan-Duval E, Klopp C, Servin B, Pitel F, Duclos MJ, Guillou H, Lusis AJ, Demeure O, Lagarrigue S.

G3 (Bethesda). 2015 Feb 3;5(4):517-29. doi: 10.1534/g3.115.016865.

6.

Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits.

Amano S, Kegelmeyer D, Hong SL.

Front Syst Neurosci. 2015 Jan 6;8:242. doi: 10.3389/fnsys.2014.00242. eCollection 2014.

7.

A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.

Chen L, Xie Z, Turkson S, Zhuang X.

J Neurosci. 2015 Jan 21;35(3):890-905. doi: 10.1523/JNEUROSCI.0089-14.2015.

PMID:
25609609
8.

Parkinson's disease: animal models and dopaminergic cell vulnerability.

Blesa J, Przedborski S.

Front Neuroanat. 2014 Dec 15;8:155. doi: 10.3389/fnana.2014.00155. eCollection 2014. Review.

9.

Models of α-synuclein aggregation in Parkinson's disease.

Giráldez-Pérez R, Antolín-Vallespín M, Muñoz M, Sánchez-Capelo A.

Acta Neuropathol Commun. 2014 Dec 13;2:176. doi: 10.1186/s40478-014-0176-9. Review.

10.

Upregulation of Parkin in endophilin mutant mice.

Cao M, Milosevic I, Giovedi S, De Camilli P.

J Neurosci. 2014 Dec 3;34(49):16544-9. doi: 10.1523/JNEUROSCI.1710-14.2014.

11.

Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.

McKeon JE, Sha D, Li L, Chin LS.

Cell Mol Life Sci. 2015 May;72(9):1811-24. doi: 10.1007/s00018-014-1781-2. Epub 2014 Nov 18.

PMID:
25403879
12.

Efficient bi-allelic gene knockout and site-specific knock-in mediated by TALENs in pigs.

Yao J, Huang J, Hai T, Wang X, Qin G, Zhang H, Wu R, Cao C, Xi JJ, Yuan Z, Zhao J.

Sci Rep. 2014 Nov 5;4:6926. doi: 10.1038/srep06926.

13.

Protein quality control in the endoplasmic reticulum.

Koenig PA, Ploegh HL.

F1000Prime Rep. 2014 Jul 8;6:49. doi: 10.12703/P6-49. eCollection 2014. Review.

14.

Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin.

Ashrafi G, Schlehe JS, LaVoie MJ, Schwarz TL.

J Cell Biol. 2014 Sep 1;206(5):655-70. doi: 10.1083/jcb.201401070. Epub 2014 Aug 25.

15.

A new pathway for mitochondrial quality control: mitochondrial-derived vesicles.

Sugiura A, McLelland GL, Fon EA, McBride HM.

EMBO J. 2014 Oct 1;33(19):2142-56. doi: 10.15252/embj.201488104. Epub 2014 Aug 8. Review.

PMID:
25107473
16.

Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.

Romaní-Aumedes J, Canal M, Martín-Flores N, Sun X, Pérez-Fernández V, Wewering S, Fernández-Santiago R, Ezquerra M, Pont-Sunyer C, Lafuente A, Alberch J, Luebbert H, Tolosa E, Levy OA, Greene LA, Malagelada C.

Cell Death Dis. 2014 Aug 7;5:e1364. doi: 10.1038/cddis.2014.333.

17.

Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD.

Mizumura K, Cloonan SM, Nakahira K, Bhashyam AR, Cervo M, Kitada T, Glass K, Owen CA, Mahmood A, Washko GR, Hashimoto S, Ryter SW, Choi AM.

J Clin Invest. 2014 Sep;124(9):3987-4003. doi: 10.1172/JCI74985. Epub 2014 Aug 1.

18.

Genetics and genomics of Parkinson's disease.

Lin MK, Farrer MJ.

Genome Med. 2014 Jun 30;6(6):48. doi: 10.1186/gm566. eCollection 2014. Review.

19.

Tissue- and cell-specific mitochondrial defect in Parkin-deficient mice.

Damiano M, Gautier CA, Bulteau AL, Ferrando-Miguel R, Gouarne C, Paoli MG, Pruss R, Auchère F, L'Hermitte-Stead C, Bouillaud F, Brice A, Corti O, Lombès A.

PLoS One. 2014 Jun 24;9(6):e99898. doi: 10.1371/journal.pone.0099898. eCollection 2014.

20.

Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene.

La Cognata V, Iemmolo R, D'Agata V, Scuderi S, Drago F, Zappia M, Cavallaro S.

Curr Genomics. 2014 Jun;15(3):203-16. doi: 10.2174/1389202915666140426003342.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk